Trial intelligence / Profile preview

F-18 NaF PET/CT for Prostate Cancer Bone Metastases

NCT01240551Phase 2Completed

Sponsor
National Cancer Institute
Start
Nov 2010
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium fluoride f-18 in prostate cancer (PCa), sponsored by National Cancer Institute. Started Nov 2010; status: completed.

02

Drugs

sodium fluoride f-18
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT01240551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01240551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call